✦ LIBER ✦

A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage Colony-Stimulating Factor Is an Effective Rescue for Patients with Aggressive Lymphoma Failing Autologous Stem Cell Transplantation

✍ Scribed by Attilio Olivieri; Moira Lucesole; Debora Capelli; Guido Gini; Mauro Montanari; Marco Candela; Emanuela Troiani; Ilaria Scortechini; Antonella Poloni; Pietro Leoni

Book ID: 116278330
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 452 KB
Volume: 11
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2005.05.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-Dose Etoposide Plus Granulocyte Col

High-Dose Etoposide Plus Granulocyte Colony-Stimulating Factor as an Effective Chemomobilization Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma Previously Treated with CHOP-based Chemotherapy: A Study from the Consortium for Improving Survival of Lymphoma

✍ Hyun, Shin Young; Cheong, June-Won; Kim, Soo-Jeong; Min, Yoo Hong; Yang, Deok-Hw 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 260 KB